Volume 3, Issue 10.In this podcast, Dr. Roma Gianchandani from the University of Michigan identifies scenarios in which patients can benefit from ultralong-acting insulins and discuss the potential negatives of ultralong-acting insulins.Take our post-test to claim CME credits:Physician post-testNurse post-testTo read a companion newsletter click here.The post Clinical Implications of CGM in Patients with Type 2 appeared first on DKBmed Radio. See acast.com/privacy for privacy and opt-out information.